Skip to main content
Erschienen in: Indian Journal of Gastroenterology 1/2011

01.02.2011

Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry

verfasst von: Dipti Chourasia, Asha Misra, Shweta Tripathi, Narendra Krishnani, Uday C. Ghoshal

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background and aim

The relationship between gastroesophageal reflux disease (GERD) and Helicobacter pylori is controversial. We evaluated endoscopic, 24-h gastric and esophageal acid profile among patients with GERD in relation to H. pylori, as the latter might alter gastric acid secretion.

Methods

Patients with GERD (n = 123), who were not on acid-suppressive drugs, and had not received anti-H. pylori therapy, underwent gastroduodenoscopy and tests for H. pylori detection. Esophageal manometry, 24-h pH metry, serum pepsinogen-I (PG-I), PG-II and gastrin-17 ELISA were done in all these patients. Univariate and multivariate analyses were performed to assess independent predictors for erosive esophagitis (EE).

Results

Of 123 patients (mean age 40.5 [13.1] years, 85 [69.1%] men), 59 (47.9%) had H. pylori infection. EE was more common in H. pylori non-infected than infected (49 vs. 32, p < 0.001). Among patients older than 40 years, absence of H. pylori was associated with lower esophageal pH and longer reflux (p = 0.02 and p < 0.001, respectively). PG-I/PG-II ratio was lower in H. pylori infected subjects (p < 0.001). In patients with higher LA grade of esophagitis, elevated PG-I levels and PG-I/PG-II ratio were associated with more acidic stomach (p = 0.04 and p = 0.01, respectively). Multivariate analyses showed low gastrin-17 (p = 0.016), higher age (p = 0.013), hiatus hernia (p = 0.004) and absence of H. pylori (p = 0.03) were independent predictors for risk of EE.

Conclusion

H. pylori infection is associated with less acidic stomach and less severe GERD. Low gastrin-17, higher age, hiatus hernia and absence of H. pylori were the best predictors for EE risk.
Literatur
1.
Zurück zum Zitat El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998;43:327–33.PubMedCrossRef El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998;43:327–33.PubMedCrossRef
2.
Zurück zum Zitat Falk GW. GERD and H. pylori: is there a link? Semin Gastrointest Dis. 2001;12:16–25.PubMed Falk GW. GERD and H. pylori: is there a link? Semin Gastrointest Dis. 2001;12:16–25.PubMed
3.
Zurück zum Zitat Holtmann G. Reflux disease: the disorder of the third millennium. Eur J Gastroenterol Hepatol. 2001;13 Suppl 1:S5–11.PubMed Holtmann G. Reflux disease: the disorder of the third millennium. Eur J Gastroenterol Hepatol. 2001;13 Suppl 1:S5–11.PubMed
4.
Zurück zum Zitat Kahrilas PJ, Lee TJ. Pathophysiology of gastroesophageal reflux disease. Thorac Surg Clin. 2005;15:323–33.PubMedCrossRef Kahrilas PJ, Lee TJ. Pathophysiology of gastroesophageal reflux disease. Thorac Surg Clin. 2005;15:323–33.PubMedCrossRef
5.
Zurück zum Zitat Terry P, Lagergren J, Wolk A, Nyren O. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer. 2000;38:186–91.PubMedCrossRef Terry P, Lagergren J, Wolk A, Nyren O. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer. 2000;38:186–91.PubMedCrossRef
6.
Zurück zum Zitat Holtmann G, Adam B, Liebregts T. Review article: the patient with gastro-oesophageal reflux disease–lifestyle advice and medication. Aliment Pharmacol Ther. 2004;20 Suppl 8:24–7.PubMedCrossRef Holtmann G, Adam B, Liebregts T. Review article: the patient with gastro-oesophageal reflux disease–lifestyle advice and medication. Aliment Pharmacol Ther. 2004;20 Suppl 8:24–7.PubMedCrossRef
7.
Zurück zum Zitat El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100:1243–50.PubMedCrossRef El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100:1243–50.PubMedCrossRef
8.
Zurück zum Zitat Ho KY, Cheung TK, Wong BC. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture? J Gastroenterol Hepatol. 2006;21:1362–5.PubMedCrossRef Ho KY, Cheung TK, Wong BC. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture? J Gastroenterol Hepatol. 2006;21:1362–5.PubMedCrossRef
9.
Zurück zum Zitat El-Omar EM. Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection. Gut. 2006;55:144–6.PubMedCrossRef El-Omar EM. Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection. Gut. 2006;55:144–6.PubMedCrossRef
10.
Zurück zum Zitat Falk GW. The possible role of Helicobacter pylori in GERD. Semin Gastrointest Dis. 2001;12:186–95.PubMed Falk GW. The possible role of Helicobacter pylori in GERD. Semin Gastrointest Dis. 2001;12:186–95.PubMed
11.
Zurück zum Zitat Garrido Serrano A, Lepe Jimenez JA, Guerrero Igea FJ, Perianes Hernandez C. Helicobacter pylori and gastroesophageal reflux disease. Rev Esp Enferm Dig. 2003;95:788–90.PubMed Garrido Serrano A, Lepe Jimenez JA, Guerrero Igea FJ, Perianes Hernandez C. Helicobacter pylori and gastroesophageal reflux disease. Rev Esp Enferm Dig. 2003;95:788–90.PubMed
12.
Zurück zum Zitat Fallone CA, Barkun AN, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol. 2000;95:914–20.PubMedCrossRef Fallone CA, Barkun AN, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol. 2000;95:914–20.PubMedCrossRef
13.
Zurück zum Zitat Gisbert JP, Pajares JM, Losa C. Helicobacter pylori and gastroesophageal reflux disease: friends or foes? Hepatogastroenterology. 1999;46:1023–9.PubMed Gisbert JP, Pajares JM, Losa C. Helicobacter pylori and gastroesophageal reflux disease: friends or foes? Hepatogastroenterology. 1999;46:1023–9.PubMed
14.
Zurück zum Zitat Haruma K. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20 Suppl 8:40–4.PubMedCrossRef Haruma K. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20 Suppl 8:40–4.PubMedCrossRef
15.
Zurück zum Zitat Richter J. Do we know the cause of reflux disease? Eur J Gastroenterol Hepatol. 1999;11 Suppl 1:S3–9.PubMed Richter J. Do we know the cause of reflux disease? Eur J Gastroenterol Hepatol. 1999;11 Suppl 1:S3–9.PubMed
16.
Zurück zum Zitat Wu JC, Sung JJ, Ng EK, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol. 1999;94:1790–4.PubMedCrossRef Wu JC, Sung JJ, Ng EK, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol. 1999;94:1790–4.PubMedCrossRef
17.
Zurück zum Zitat Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003;18:279–89.PubMedCrossRef Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003;18:279–89.PubMedCrossRef
18.
Zurück zum Zitat El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995;109:681–91.PubMedCrossRef El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995;109:681–91.PubMedCrossRef
19.
Zurück zum Zitat Vicari J, Falk GW, Richter JE. Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable? Am J Gastroenterol. 1997;92:1097–102.PubMed Vicari J, Falk GW, Richter JE. Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable? Am J Gastroenterol. 1997;92:1097–102.PubMed
20.
Zurück zum Zitat Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50–7.PubMedCrossRef Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50–7.PubMedCrossRef
21.
Zurück zum Zitat Chourasia D, Ghoshal UC. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play? Trop Gastroenterol. 2008;29:13–9.PubMed Chourasia D, Ghoshal UC. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play? Trop Gastroenterol. 2008;29:13–9.PubMed
22.
Zurück zum Zitat Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology. 1986;90:570–6.PubMed Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology. 1986;90:570–6.PubMed
23.
Zurück zum Zitat Monkemuller K, Neumann H, Nocon M, et al. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther. 2008;28:491–6.PubMedCrossRef Monkemuller K, Neumann H, Nocon M, et al. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther. 2008;28:491–6.PubMedCrossRef
24.
Zurück zum Zitat Kwon JH, Chung IS, Son HS, et al. The relationship of gastrin, pepsinogen, and Helicobacter pylori in erosive reflux esophagitis. Korean J Gastroenterol. 2008;51:159–66.PubMed Kwon JH, Chung IS, Son HS, et al. The relationship of gastrin, pepsinogen, and Helicobacter pylori in erosive reflux esophagitis. Korean J Gastroenterol. 2008;51:159–66.PubMed
25.
Zurück zum Zitat Dockray GJ. Clinical endocrinology and metabolism. Gastrin. Best Pract Res Clin Endocrinol Metab. 2004;18:555–68.PubMedCrossRef Dockray GJ. Clinical endocrinology and metabolism. Gastrin. Best Pract Res Clin Endocrinol Metab. 2004;18:555–68.PubMedCrossRef
26.
Zurück zum Zitat Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut. 1993;34:1032–7.PubMedCrossRef Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut. 1993;34:1032–7.PubMedCrossRef
27.
Zurück zum Zitat Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol. 2004;99:1213–21.PubMedCrossRef Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol. 2004;99:1213–21.PubMedCrossRef
28.
Zurück zum Zitat Grande M, Cadeddu F, Villa M, et al. Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol. 2008;6:74.PubMedCrossRef Grande M, Cadeddu F, Villa M, et al. Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol. 2008;6:74.PubMedCrossRef
29.
Zurück zum Zitat Ando T, El-Omar EM, Goto Y, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut. 2006;55:158–64.PubMedCrossRef Ando T, El-Omar EM, Goto Y, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut. 2006;55:158–64.PubMedCrossRef
30.
Zurück zum Zitat Saraswat VA, Dhiman RK, Mishra A, Naik SR. Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. Dig Dis Sci. 1994;39:199–205.PubMedCrossRef Saraswat VA, Dhiman RK, Mishra A, Naik SR. Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. Dig Dis Sci. 1994;39:199–205.PubMedCrossRef
31.
Zurück zum Zitat Collins BJ, Elliott H, Sloan JM, McFarland RJ, Love AH. Oesophageal histology in reflux oesophagitis. J Clin Pathol. 1985;38:1265–72.PubMedCrossRef Collins BJ, Elliott H, Sloan JM, McFarland RJ, Love AH. Oesophageal histology in reflux oesophagitis. J Clin Pathol. 1985;38:1265–72.PubMedCrossRef
32.
Zurück zum Zitat Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.PubMedCrossRef Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.PubMedCrossRef
33.
Zurück zum Zitat Bilgen C, Ogut F, Kesimli-Dinc H, Kirazli T, Bor S. The comparison of an empiric proton pump inhibitor trial vs. 24-hour double-probe pH monitoring in laryngopharyngeal reflux. J Laryngol Otol. 2003;117:386–90.PubMedCrossRef Bilgen C, Ogut F, Kesimli-Dinc H, Kirazli T, Bor S. The comparison of an empiric proton pump inhibitor trial vs. 24-hour double-probe pH monitoring in laryngopharyngeal reflux. J Laryngol Otol. 2003;117:386–90.PubMedCrossRef
34.
Zurück zum Zitat Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRef Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.PubMedCrossRef
35.
Zurück zum Zitat Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg. 2001;136:1267–73.PubMedCrossRef Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg. 2001;136:1267–73.PubMedCrossRef
36.
Zurück zum Zitat Ghoshal UC, Ghosh TK, Ghoshal U, Shujaatullah F, Banerjee PK, Mazumder DN. In-house rapid urease test kit and commercial kit: which is better? Indian J Gastroenterol. 1999;18:183.PubMed Ghoshal UC, Ghosh TK, Ghoshal U, Shujaatullah F, Banerjee PK, Mazumder DN. In-house rapid urease test kit and commercial kit: which is better? Indian J Gastroenterol. 1999;18:183.PubMed
37.
Zurück zum Zitat Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008;53:1215–22.PubMedCrossRef Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008;53:1215–22.PubMedCrossRef
38.
Zurück zum Zitat Ghoshal UC, Chourasia D, Tripathi S, Misra A, Singh K. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry. Scand J Gastroenterol. 2008;43:654–61.PubMedCrossRef Ghoshal UC, Chourasia D, Tripathi S, Misra A, Singh K. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry. Scand J Gastroenterol. 2008;43:654–61.PubMedCrossRef
39.
Zurück zum Zitat Gisbert JP, de Pedro A, Losa C, Barreiro A, Pajares JM. Helicobacter pylori and gastroesophageal reflux disease: lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings. J Clin Gastroenterol. 2001;32:210–4.PubMedCrossRef Gisbert JP, de Pedro A, Losa C, Barreiro A, Pajares JM. Helicobacter pylori and gastroesophageal reflux disease: lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings. J Clin Gastroenterol. 2001;32:210–4.PubMedCrossRef
40.
Zurück zum Zitat Zerbib F, Bicheler V, Leray V, Joubert M, Bruley des Varannes S, Galmiche JP. H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans. Am J Physiol Gastrointest Liver Physiol. 2001;281:G350–6.PubMed Zerbib F, Bicheler V, Leray V, Joubert M, Bruley des Varannes S, Galmiche JP. H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans. Am J Physiol Gastrointest Liver Physiol. 2001;281:G350–6.PubMed
41.
Zurück zum Zitat Goldschmiedt M, Barnett CC, Schwarz BE, Karnes WE, Redfern JS, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology. 1991;101:977–90.PubMed Goldschmiedt M, Barnett CC, Schwarz BE, Karnes WE, Redfern JS, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology. 1991;101:977–90.PubMed
42.
Zurück zum Zitat Moschos J, Kouklakis G, Lyratzopoulos N, Efremidou E, Maltezos E, Minopoulos G. Gastroesophageal reflux disease and Helicobacter pylori: lack of influence of infection on oesophageal manometric, 3-hour postprandial pHmetric and endoscopic findings. Rom J Gastroenterol. 2005;14:351–5.PubMed Moschos J, Kouklakis G, Lyratzopoulos N, Efremidou E, Maltezos E, Minopoulos G. Gastroesophageal reflux disease and Helicobacter pylori: lack of influence of infection on oesophageal manometric, 3-hour postprandial pHmetric and endoscopic findings. Rom J Gastroenterol. 2005;14:351–5.PubMed
43.
Zurück zum Zitat Haruma K, Kamada T, Kawaguchi H, et al. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol. 2000;15:277–83.PubMedCrossRef Haruma K, Kamada T, Kawaguchi H, et al. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol. 2000;15:277–83.PubMedCrossRef
44.
Zurück zum Zitat Derakhshan MH, El-Omar E, Oien K, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol. 2006;59:1293–9.PubMedCrossRef Derakhshan MH, El-Omar E, Oien K, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol. 2006;59:1293–9.PubMedCrossRef
45.
Zurück zum Zitat Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol. 2004;99:1652–6.PubMedCrossRef Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol. 2004;99:1652–6.PubMedCrossRef
46.
Zurück zum Zitat Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Harkonen M. Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol. 2005;11:5988–92.PubMed Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Harkonen M. Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol. 2005;11:5988–92.PubMed
47.
Zurück zum Zitat Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol Suppl. 1994;201:7–10.PubMedCrossRef Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol Suppl. 1994;201:7–10.PubMedCrossRef
48.
Zurück zum Zitat Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol. 1998;93:1800–2.PubMedCrossRef Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol. 1998;93:1800–2.PubMedCrossRef
49.
Zurück zum Zitat Kahrilas PJ. GERD revisited: advances in pathogenesis. Hepatogastroenterology. 1998;45:1301–7.PubMed Kahrilas PJ. GERD revisited: advances in pathogenesis. Hepatogastroenterology. 1998;45:1301–7.PubMed
50.
Zurück zum Zitat Kahrilas PJ. The role of hiatus hernia in GERD. Yale J Biol Med. 1999;72:101–11.PubMed Kahrilas PJ. The role of hiatus hernia in GERD. Yale J Biol Med. 1999;72:101–11.PubMed
51.
Zurück zum Zitat Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008;27:173–85.PubMedCrossRef Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008;27:173–85.PubMedCrossRef
52.
Zurück zum Zitat Tsukada K, Katoh H, Miyazaki T, et al. Factors associated with the development of reflux esophagitis after Helicobacter pylori eradication. Dig Dis Sci. 2006;51:539–42.PubMedCrossRef Tsukada K, Katoh H, Miyazaki T, et al. Factors associated with the development of reflux esophagitis after Helicobacter pylori eradication. Dig Dis Sci. 2006;51:539–42.PubMedCrossRef
53.
Zurück zum Zitat Moon A, Solomon A, Beneck D, Cunningham-Rundles S. Positive association between Helicobacter pylori and gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2009;49:283–8. Moon A, Solomon A, Beneck D, Cunningham-Rundles S. Positive association between Helicobacter pylori and gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2009;49:283–8.
54.
Zurück zum Zitat Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 1997;92:1997–2000.PubMed Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 1997;92:1997–2000.PubMed
55.
Zurück zum Zitat Fass R, Fennerty MB, Johnson C, Camargo L, Sampliner RE. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol. 1999;28:36–9.PubMedCrossRef Fass R, Fennerty MB, Johnson C, Camargo L, Sampliner RE. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol. 1999;28:36–9.PubMedCrossRef
56.
Zurück zum Zitat Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol. 2009;104:2704–13.PubMedCrossRef Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol. 2009;104:2704–13.PubMedCrossRef
Metadaten
Titel
Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry
verfasst von
Dipti Chourasia
Asha Misra
Shweta Tripathi
Narendra Krishnani
Uday C. Ghoshal
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 1/2011
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-010-0078-0

Weitere Artikel der Ausgabe 1/2011

Indian Journal of Gastroenterology 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.